David B. Seligson
#121,702
Most Influential Person Now
David B. Seligson's AcademicInfluence.com Rankings
David B. Seligsonchemistry Degrees
Chemistry
#2633
World Rank
#3565
Historical Rank
Organic Chemistry
#394
World Rank
#465
Historical Rank
Download Badge
Chemistry
Why Is David B. Seligson Influential?
(Suggest an Edit or Addition)David B. Seligson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical Chemistry (1965) (2305)
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles (2010) (2274)
- Global histone modification patterns predict risk of prostate cancer recurrence (2005) (1064)
- Standard Methods of Clinical Chemistry (1970) (908)
- Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. (2003) (665)
- Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. (2011) (593)
- Global levels of histone modifications predict prognosis in different cancers. (2009) (489)
- Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. (2003) (449)
- Prognostic relevance of the mTOR pathway in renal cell carcinoma (2007) (357)
- A microdiffusion method for the determination of nitrogen liberated as ammonia. (1951) (301)
- Identification of molecular subtypes of glioblastoma by gene expression profiling (2003) (280)
- The measurement of ammonia in whole blood, erythrocytes, and plasma. (1957) (235)
- Using Protein Expressions to Predict Survival in Clear Cell Renal Carcinoma (2004) (223)
- Histone acetylation regulates intracellular pH. (2013) (213)
- Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. (2010) (202)
- A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. (1953) (197)
- Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma (2005) (194)
- Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma. (2004) (193)
- A molecular classification of papillary renal cell carcinoma. (2005) (186)
- Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma. (2005) (178)
- Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy (2009) (170)
- Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma (2009) (168)
- APPLICATION OF ATOMIC ABSORPTION SPECTROPHOTOMETRY IN THE DETERMINATION OF CALCIUM IN SERUM. (1964) (167)
- The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. (1983) (167)
- Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma (2005) (163)
- Hypoxia-Inducible Factor 1α in Clear Cell Renal Cell Carcinoma (2007) (158)
- Expression of transcription factor Yin Yang 1 in prostate cancer. (2005) (156)
- Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients. (2009) (153)
- COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer (2004) (143)
- Aromatase expression predicts survival in women with early-stage non small cell lung cancer. (2007) (141)
- Determination of sulfobromophthalein in serum. (1957) (132)
- Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. (2006) (131)
- Prostate stem cell antigen expression is associated with gleason score, seminal vesicle invasion and capsular invasion in prostate cancer. (2004) (130)
- Epithelial Cell Adhesion Molecule (KSA) Expression (2004) (127)
- Genomic Landscape of Meningiomas (2009) (120)
- Reciprocal Regulation of SOCS 1 and SOCS3 Enhances Resistance to Ionizing Radiation in Glioblastoma Multiforme (2007) (107)
- Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples (2008) (104)
- Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma. (2003) (101)
- Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression (2002) (99)
- p53 is an independent predictor of tumor recurrence and progression after nephrectomy in patients with localized renal cell carcinoma. (2005) (97)
- Measurement of thyroxine by competitive protein binding. (1972) (91)
- Alpha-keto acids in blood and urine studied by paper chromatography. (1952) (90)
- Tissue microarray analysis of cytoskeletal actin‐associated biomarkers gelsolin and E‐cadherin in urothelial carcinoma (2002) (87)
- Expression of X-Linked Inhibitor of Apoptosis Protein Is a Strong Predictor of Human Prostate Cancer Recurrence (2007) (86)
- Analysis of the Na,K‐ATPase α‐ and β‐subunit expression profiles of bladder cancer using tissue microarrays (2003) (86)
- Lymphomatosis cerebri Presenting as a Rapidly Progressive Dementia: Clinical, Neuroimaging and Pathologic Findings (1999) (85)
- Loss of CD10 (neutral endopeptidase) is a frequent and early event in human prostate cancer (2003) (81)
- Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma (2010) (76)
- Loss of annexin A1 expression in human breast cancer detected by multiple high-throughput analyses. (2004) (76)
- The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. (2007) (72)
- Flap endonuclease 1 is overexpressed in prostate cancer and is associated with a high Gleason score (2006) (71)
- p21 is a prognostic marker for renal cell carcinoma: implications for novel therapeutic approaches. (2007) (69)
- Carbonic anhydrase IX in bladder cancer (2009) (68)
- Statistical Methods for Analyzing Tissue Microarray Data (2004) (68)
- Irreversible binding of conjugated bilirubin to albumin in cholestatic rats. (1984) (66)
- Trefoil factor 3 is overexpressed in human prostate cancer (2004) (58)
- Nephelometric determination of pancreatic enzymes (1973) (56)
- CA9 gene: single nucleotide polymorphism predicts metastatic renal cell carcinoma prognosis. (2009) (53)
- Analysis of the Na,K-ATPase alpha- and beta-subunit expression profiles of bladder cancer using tissue microarrays. (2003) (52)
- Expression of epithelial membrane protein‐2 is associated with endometrial adenocarcinoma of unfavorable outcome (2006) (50)
- Nephelometric determination of pancreatic enzymes. II. Lipase. (1973) (47)
- Expression of arginase II in prostate cancer. (2008) (45)
- Pathological, immunohistochemical and cytogenetic features of papillary renal cell carcinoma with clear cell features. (2011) (44)
- A multicenter study of prevalence and risk factors for aberrant crypt foci. (2009) (42)
- Smoking negatively impacts renal cell carcinoma overall and cancer‐specific survival (2012) (41)
- Na,K-adenosine triphosphatase alpha1-subunit predicts survival of renal clear cell carcinoma. (2008) (40)
- The natural history of aberrant crypt foci. (2008) (39)
- Protein expression analysis using quantitative fluorescence image analysis on tissue microarray slides. (2002) (36)
- Studies on blood ammonia in normal and shock states. (1953) (35)
- Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. (2010) (34)
- Microtechniques of Clinical Chemistry (1962) (33)
- Epithelial membrane protein‐2 expression is an early predictor of endometrial cancer development (2010) (32)
- New method for rapid determination of carboxyhemoglobin by use of double-wavelength spectrophotometry. (1974) (32)
- A Syllabus of Laboratory Examinations in Clinical Diagnosis (1961) (31)
- 236: Carbonic Anhydrase IX (CAIX) in Bladder Cancer: A Diagnostic, Prognostic and Therapeutic Molecular Marker (2007) (31)
- Clinical, molecular, and genetic correlates of lymphatic spread in clear cell renal cell carcinoma. (2012) (30)
- THE ISOLATION OF SEVERAL AROMATIC ACIDS FROM THE HEMODIALYSIS FLUIDS OF UREMIC PATIENTS. (1965) (30)
- A new "kinetic" method for enzyme analysis suitable for automation. (1969) (29)
- IGFBP-3 Nuclear Localization Predicts Human Prostate Cancer Recurrence (2013) (29)
- Gene expression and tissue microarray analysis of interleukin-2 complete responders in patients with metastatic renal cell carcinoma (2005) (28)
- Poor prognosis and advanced clinicopathological features of clear cell renal cell carcinoma (ccRCC) are associated with cytoplasmic subcellular localisation of Hypoxia inducible factor-2α. (2014) (28)
- Ionic activities of sodium, potassium, and chloride in human serum. (1968) (28)
- Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci. (2009) (27)
- Expression Pattern of the Novel Gene EG-1 in Cancer (2004) (27)
- Tissue Microarrays in the Study of Non‐Neoplastic Disease of the Nervous System (2002) (26)
- Elevated MED28 expression predicts poor outcome in women with breast cancer (2010) (26)
- Systemic delivery of siRNA via targeted nanoparticles in patients with cancer: Results from a first-in-class phase I clinical trial. (2010) (25)
- Characterization of the mTOR pathway in renal cell carcinoma and its use in predicting patient selection for agents targeting this pathway (2005) (25)
- Use of serum transaminase levels in the differentiation of pulmonary embolism and myocardial infarction. (1956) (25)
- The conversion of alloxan to alloxanic acid in plasma. (1951) (25)
- Estimation of unconjugated, conjugated, and "delta" bilirubin fractions in serum by use of two coated thin films. (1984) (24)
- Targeting the vascular endothelial growth factor pathway in renal cell carcinoma: A tissue array based analysis (2005) (24)
- Expression of the vascular endothelial growth factor family in tumor dissemination and disease free survival in clear cell renal cell carcinoma (2005) (23)
- Experimental hepatic coma. (1953) (21)
- Renal tubular acidosis with organic aciduria during paraldehyde ingestion; six year study of an unusual case. (1957) (20)
- Availability and quality of paraffin blocks identified in pathology archives: A multi-institutional study by the Shared Pathology Informatics Network (SPIN) (2007) (19)
- Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome. (2009) (19)
- An evaluation of blood smears made by a new method using a spinner and diluted blood. (1978) (19)
- The metabolism of ethanol in man. (1958) (19)
- Direct determination of copper in urine by atomic absorption spectrophotometry. (1971) (18)
- CLINICAL and biochemical features of hepatic insufficiency. (1953) (18)
- APPLICATION OF LIQUID SCINTILLATION COUNTING TO I-131 MEASUREMENT. (1965) (17)
- Inhibition of protein synthesis by N-methyl-2-pyridone-5-formamidoacetic acid and other compounds isolated from uremic patients. (1965) (16)
- Carbonic Anhydrase IX Is an Independent Predictor of Survival in Advanced Renal Clear Cell Carcinoma (2003) (16)
- The tissue micro-array as a translational research tool for biomarker profiling and validation (2005) (15)
- Serum lipase. A rapid photometric method. (1967) (15)
- An automatic pipetting device and its application in the clinical laboratory. (1957) (15)
- Significance of abnormally low blood urea levels. (1962) (14)
- Epinephrine and norepinephrine in pregnancy and labor. (1959) (14)
- ISOLATION OF N-METHYL-2-PYRIDONE-5-CARBOXAMIDE FROM HEMODIALYSIS FLUID OBTAINED FROM UREMIC PATIENTS. (1964) (14)
- Measurement of serum thyroxine-binding capacity. (1978) (14)
- One Year Recurrence of Aberrant Crypt Foci (2010) (13)
- Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors (2003) (13)
- Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma. (2008) (13)
- 8q24 Amplification in Transitional Cell Carcinoma of Bladder (2003) (12)
- An anion-exchange chromatographic method for measuring bilirubin covalently bound to albumin. (1985) (12)
- Phenolic acids in experimental uremia. I. Potential role of phenolic acids in the neurological manifestations of uremia. (1969) (12)
- Direct determination of total serum cholesterol by use of double-wavelength spectrophotometry. (1975) (12)
- Micro-electrolytic iodination of polypeptide hormones for radio-immunoassay. (1972) (11)
- Erratum: Genomic Landscape of Meningiomas (Brain Pathology (2010) 20 (751-762)) (2011) (11)
- Measurement of 5,5-diphenylhydantoin in blood using thin-layer chromatography. (1971) (11)
- The Chemistry of The Injured Cell (1962) (10)
- Turbidimetric Measurement of Amylase: Standardization and Control with Stable Serum* (1963) (10)
- Hypoxia-Inducible Factor 1A in Clear Cell Renal Cell Carcinoma (2007) (10)
- Measurement of uric acid in biologic fluids using an ion-exchange separation. (1957) (10)
- Expression of thyroid transcription factor-1 in normal endometrium is associated with risk of endometrial cancer development (2012) (10)
- Microdetermination of Carbon Dioxide Liberated by Acidification or Oxidation (1951) (9)
- MAGE-B2 Autoantibody: A New Biomarker for Pediatric Systemic Lupus Erythematosus (2008) (9)
- Clinical laboratory automation. (1966) (8)
- Studies on prestress in bone. (1982) (8)
- ELEVATIONS OF SERUM GLUTAMIC–OXALACETIC TRANSAMINASE AND URINARY COPROPORPHYRINS IN PSEUDOHYPERTROPHIC MUSCULAR DYSTROPHY (1957) (8)
- ANALOG COMPUTATION OF ELECTROPHORESIS PATTERNS. (1965) (8)
- PROCEDURE FOR ISOLATION AND IDENTIFICATION OF MINUTE AMOUNTS OF PHENOLIC ACIDS USING PAPER CHROMATOGRAPHY AND INFRARED SPECTROSCOPY. (1963) (8)
- EVALUATION OF A CHOLESTEROL "KIT". (1964) (8)
- Nephelometric determination of pancreatic enzymes. I. Amylase. (1973) (8)
- Electrometric method for the determination of chloride in serum and other biologic fluids. (1958) (7)
- Automatic discrete sample processing. Automation in a clinical chemistry laboratory based on discrete sample handling and computerized data processing. (1969) (7)
- Cyclooxygenase-2-dependent expression of survivin in non-small cell lung cancer. (2004) (6)
- Serum glutamic oxalacetic transaminase and iron in the differential diagnosis of jaundice. (1959) (6)
- N-methyl-2-pyridone-5-carboxylic acid and N-methyl-2-pyridone-5-formamidoacetic acid isolated from dialysis fluids of uremic patients (1965) (6)
- Diazo-based assay for total bilirubin in a coated thin film evaluated. (1984) (6)
- Sulfobromophthalein (BSP) in Serum (1958) (6)
- Standardization of methods in clinical chemistry. (1957) (6)
- Serotonin in Pregnant and Parturient Women (1959) (5)
- An improved method for the determination of amino acids in small samples of blood and urine. (1950) (5)
- 1651: Molecular Prognostic Modeling Using Protein Expression Profile in Clear Cell Renal Carcinoma (2004) (5)
- 350: Characterization of the MTOR Pathway in Renal Cell Carcinoma and its Use in Predicting Patient Selection for Agents Targeting this Pathway (2005) (4)
- Studies on an unidentified product of alloxan metabolism in urine. (1953) (4)
- A PHOTOMETRIC SYSTEM FOR AUTOMATICALLY READING CONCENTRATION. (1964) (4)
- A system of microchemistry for the hospital laboratory designed for maintenance of a high standard of performance. (1959) (4)
- PAPILLARY RENAL CELL CARCINOMA WITH CLEAR CELLS – PATHOLOGICAL, IMMUNOHISTOCHEMICAL AND CYTOGENETIC CHARACTERISTICS OF A NOVEL ENTITY (2008) (4)
- Automation and labor-saving devices in the clinical laboratory. (1961) (4)
- The differentiation of medical from surgical jaundice by means of serum transaminase and iron determinations. (1958) (4)
- ADAPTATION OF A PHOTOELECTRIC COLORIMETER TO A COMPUTER PROGRAM FOR CALCULATING AND STORING DATA IN A CLINICAL CHEMISTRY LABORATORY. (1964) (3)
- The acute reduction in plasma amino acids by carbohydrate infusion in diabetes and liver disease. (1958) (3)
- Effect of Aureomycin on Liver Fat and Liver Function (1951) (3)
- SOME THOUGHTS ON ENZYME MEASUREMENT (1974) (3)
- The toxic effects of modified human globin. (1953) (3)
- An electrical method for analog computation of a back titration applied to the determination of serum bicarbonate. (1965) (3)
- 718: The P21 Growth and Apoptosis Regulatory Protein is an Independent Predictor of Survival in Patients with Clear Cell Renal Cell Carcinoma (2006) (3)
- Titelbild: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. 13/2011) (2011) (3)
- Application of a digital computer to emergency toxicology. (1974) (3)
- Cover Picture: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. Int. Ed. 13/2011) (2011) (2)
- Serum iron and transaminase in the differential diagnosis of jaundice. (1957) (2)
- P53 IS AN INDEPENDENT PREDICTOR OF TUMOR RECURRENCE AND PROGRESSION AFTER NEPHRECTOMY IN PATIENTS WITH LOCALIZED RCC (2005) (2)
- Measurement of serum cholesterol. (1971) (2)
- Tissue Microarrays: Construction and Utilization for Biomarker Studies (2008) (2)
- A photometric method for the determination of fatty acids. Application to serum. (1967) (2)
- ReciprocalRegulationofSOCS 1 and SOCS 3 Enhances Resistance to Ionizing Radiation in GlioblastomaMultiforme (2007) (2)
- 621: Molecular Tumor Grading of Clear Cell Renal Cell Carcinoma Using Protein Expression of the Vascular Endothelial Growth Factor (VEGF) Family (2005) (2)
- An automatic pipetting device and its application in the clinical laboratory. (1957) (1)
- Aberrant regulation of SOCS1 and SOCS3 enhances resistance to ionizing radiation in glioblastoma multiforme. (2006) (1)
- Fyn and Src are Effectors of Oncogenic EGFR Signaling in Glioblastoma Patients (2009) (1)
- Automatic pipeting attachment for the Van Slyke manometric apparatus for CO2 determination. (1958) (1)
- Clinical, pathological, and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma (2004) (1)
- 4 - Tissue Microarray and Quantitative Fluorescence Image Analysis in Tumor Biomarker Analysis (2005) (1)
- Blood ammonia in normal and shock states. (1953) (1)
- 491: Molecular Tumor Profiling Improves Risk Assessment and Prognostication of Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma (2007) (1)
- Effect of infusing intermediates on blood concentrations of alpha-ketoglutarate and pyruvate in dogs (1953) (1)
- Overexpression of inhibitor of apoptosis protein XIAP in human prostate cancer (2005) (1)
- 372: Expression Analysis of the Vascular Endothelial Growth Factor (VEGF) Family in Renal Cell Carcinoma: Targeting the VEGF Pathway (2006) (1)
- Instrumentation in clinical laboratory is money saved. (1962) (1)
- 1331: Expression of Vascular Endothelial Growth Factor A (VEGF-A), VEGF Receptor 1 (VEGFR-1) and VEGFR-2 in Clear Cell and Papillary Renal Cell Carcinoma (RCC): Implications for Therapy (2005) (1)
- 1337: Endothelial Expression of Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3), but not VEGFR-1 or VEGFR-2, Predicts Survival in Clear Cell Renal Cell Carcinoma (RCC) (2005) (0)
- Book ReviewClinical Chemistry: Theory, analysis, and correlation (1984) (0)
- Work Simplification in Clinical Chemistry (1966) (0)
- Book ReviewScientific Foundations of Clinical Biochemistry (1979) (0)
- Author's response to reviews Availability and quality of paraffin blocks identified in pathology archives: A multi-institutional study by Title: the Shared Pathology Informatics Network (SPIN) Authors: (2006) (0)
- Studies on the Metabolism of Alloxan. (1952) (0)
- STUDY OF THE ORGANIC ACIDS IN SERUM, URINE AND BLOOD DIALYSATE OF PATIENTS WITH MEEMIA. (1962) (0)
- Analysis of biomaterial using Neural Computing Methodology (2001) (0)
- 680Hematogenous versus lymphatic dissemination: The role of the vascular endothelial growth factor (VEGF) family in the metastatic process of clear cell renal cell carcinoma (2005) (0)
- Clinical Chemistry In Practical Medicine (1955) (0)
- Abstract 3651: Foxp3 expression correlates with survival in urothelial carcinoma of the bladder (2012) (0)
- Cancer detection using neural computing methodology (2001) (0)
- The serum glutamic oxalacetic transaminase determination: its clinical use in the diagnosis of myocardial infarction and in the differential diagnosis of chest pains. (1957) (0)
- ABSENCE OF CD44 EXPRESSION IS AN INDEPENDENT PREDICTOR OF POOR OUTCOME FOR PATIENTS WITH UROTHELIAL BLADDER CANCER (2009) (0)
- 645: Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3) is Highly Expressed in the Tumor Endothelium of Clear Cell but not Papillary Renal Cell Carcinoma (RCC): Implications for Therapy (2005) (0)
- 349: Vascular Endothelial Growth Factor Receptor 3 (VEGFR-3) is Preferentially Expressed in Papillary Renal Cell Carcinoma (RCC). (2005) (0)
- 1074 FOXP3 EXPRESSION CORRELATES WITH SURVIVAL IN UROTHELIAL CARCINOMA OF THE BLADDER (2012) (0)
- Clinical, pathological, and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. (2004) (0)
- Cytogenetic andMolecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma (2009) (0)
- P53 is an independent predictor of tumor recurrence and progression after nephrectomy for patients with localized Renal Cell Carcinoma: Implications for surveillance and adjuvant clinical trials. (2004) (0)
- Serum bilirubin pigments covalently linked to albumin. (1996) (0)
- Targeting estrogen signaling pathways for therapeutic intervention in non-small cell lung cancer. (2006) (0)
- The effect of tobacco exposure in renal cell carcinoma (RCC) overall and cancer-specific survival. (2011) (0)
- 1332: Complete Reponse to Immunotherapy in Metastatic Renal Cell Carcinoma: Gene Expression and Tissue Microarray Analysis (2005) (0)
- Use of CA9 gene single nucleotide polymorphisms to predict prognosis and treatment response of metastatic renal cell carcinoma. (2009) (0)
- A method for isolating and purifying nucleic acids from an aqueous solution (1987) (0)
- MOLECULAR PROGNOSTIC TUMOR PROFILING OF TYPE 1 AND TYPE 2 PAPILLARY RENAL CELL CARCINOMA: RELEVANCE TO THE DEVELOPMENT OF TUMOR-SPECIFIC TARGETED THERAPIES (2008) (0)
- 636: Hematogenous Versus Lymphatic Dissemination: The Role of the Vascular Endothelial Growth Factor (VEGF) Family in the Metastatic Process of Clear Cell Renal Cell Carcinoma (2005) (0)
- Book ReviewAnnual Review of Clinical Biochemistry (1980) (0)
- 572 CLINICAL, MOLECULAR AND GENETIC CORRELATES OF LYMPHATIC SPREAD IN CLEAR CELL RENAL CELL CARCINOMA (2012) (0)
- Tissue sampling and digital histologic imaging for the National Lung Screening Trial. (2010) (0)
- Cirrhosis and blood urea nitrogen. (1970) (0)
- Erythematosus MAGE-B 2 Autoantibody : A New Biomarker for Pediatric Systemic Lupus (2008) (0)
- Prognostic and biologic impact of molecular markers in papillary renal cell carcinoma (2007) (0)
- Molecular Cell Chromatin as a Rheostatic Regulator of pHi (2012) (0)
- 1071 POOR PROGNOSIS AND ADVANCED CLINICOPATHOLOGICAL FEATURES OF CLEAR CELL RENAL CELL CARCINOMA (CCRCC) ARE ASSOCIATED WITH CYTOPLASMIC SUBCELLULAR LOCALIZATION OF HIF-2α (2013) (0)
- Investigating the association of cytoplasmic and nuclear HIF-2 expression with cancer specific survival (CSS) in clear cell renal cell carcinoma. (2013) (0)
- 972: Clinical, Pathologic, and Molecular Correlations of Necrosis in the Primary Tumor of Patients with Renal Cell Carcinoma (2005) (0)
- Characterizing Complete Responders to IL-2 Using Gene Expression Analysis and Tissue Array Validation in Patients with Metastatic Renal Cell Carcinoma (2004) (0)
- Ceneral Characteristics of Coagulation Proteins Assay 351 (2008) (0)
- PANEL on liver disease. (1957) (0)
- 780: Carbonic Anhydrase IX (CAIX) Expression and VHL Gene Alteration as Predictors of Survival in Renal Cell Carcinoma (2004) (0)
- Abstract #2725: Reduced expression of Raf-1 kinase inhibitor protein (RKIP) in human lung tumors: Prognostic significance (2009) (0)
- 193 High cytoplasmic and low nuclear expression of HIF-2α are associated with worse cancer specific survival (CSS) in clear cell renal cell carcinoma (2013) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With David B. Seligson?
David B. Seligson is affiliated with the following schools:
